| Ipsen Pharma Schweiz GmbH - Ojemda 100 mg, Filmtabletten | | 70260 | | 01 | | Ojemda 100 mg | | Filmtabletten | | L01EC04 | | Tovorafenib | | 05.05.2026 | | |
| | Composition | | tovorafenibum 100 mg, copovidonum K 28, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium max. 8.46 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Tovorafenibum | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copovidonum K | 28 | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 8000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 16 | | | A | | No | | 002 | 20 | | | A | | No | | 003 | 24 | | | A | | No |
|
|
